HER2

下级目录

CUDC-101

Capivasertib

BAY1082439

CP-724714

AEE 788

Tesevatinib

TAK-285

NVP-HSP990(HSP990)

Pilaralisib

6-diaMine

Nordihydroguaiaretic acid

木利替尼

目录项下的产品

1012054-59-9 / MFCD112054599
7-[[4-(3-Ethynylphenylamino)-7-Methoxyquinazolin-6-Yl]Oxy]-N-Hydroxyheptanamide
7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羟基庚酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1143532-39-1 / MFCD243532391
(S)-4-Amino-N-(1-(4-Chlorophenyl)-3-Hydroxypropyl)-1-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Piperidine-4-Carboxamide
(S)-4-氨基-N-(1-(4-氯苯基)-3-羟丙基)-1-(7H-吡咯并[2,3-d]嘧啶-4-基)哌啶-4-甲酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1375469-38-7 / MFCD475469387
BAY1082439 is an orally bioavailable inhibitor of the class I phosphoinositide 3-kinase (PI3K) alpha and beta isoforms with potential antineoplastic activity. PI3K alpha/beta inhibitor BAY1082439 selectively inhibits both PI3K alpha, including mutated forms of PIK3CA, and PI3K beta in the PI3K/Akt/mTOR pathway, which may result in tumor cell apoptosis and growth inhibition in PI3K-expressing and/or PTEN-driven tumor cells. By specifically targeting class I PI3K alpha and beta, this agent may be more efficacious and less toxic than pan PI3K inhibitors.

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

383432-38-0 / MFCD83432380
CP-724714 is An orally bioavailable quinazoline with potential antineoplastic activity. CP-724,714 selectively binds to the intracellular domain of HER2, reversibly inhibiting its tyrosine kinase activity and resulting in suppression of tumor cell growth. HER2, a member of the epidermal growth factor receptor (EGFR) family, is overexpressed in many adenocarcinomas, particularly breast cancers.
2-甲氧基-N-[(2E)-3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

497839-62-0 / MFCD97839620
{6-[4-(4-Ethylpiperazin-1-Ylmethyl)-Phenyl]-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl}-((R)-1-Phenylethyl)Amine
{6-[4-(4-乙基哌嗪-1-基甲基)-苯基]-7H吡咯并[2,3-d]嘧啶-4-基}-((R)-1-苯基乙基)胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

781613-23-8 / MFCD81613238
N-(3,4-Dichloro-2-Fluorophenyl)-6-Methoxy-7-(((3aR,5R,6aS)-2-Methyloctahydrocyclopenta[c]Pyrrol-5-Yl)Methoxy)Quinazolin-4-Amine
N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3aR,5r,6aS)-2-甲基八氢环戊戊二烯并[c]吡咯-5-基)甲氧基)喹唑啉-4-胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

871026-44-7 / MFCD71026447
TAK-285
N-(2-(4-((3-氯-4-[3-(三氟甲基)苯氧基)苯基)氨基)-5H-吡咯并[3,2-d]嘧啶-5-基)乙基)-3-羟基-3-甲基丁酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

934343-74-5 / MFCD034343745
(R)-2-Amino-7-(4-Fluoro-2-(6-Methoxypyridin-2-Yl)Phenyl)-4-Methyl-7,8-Dihydropyrido[4,3-d]Pyrimidin-5(6H)-One
(R)-2-氨基-7-(4-氟-2-(6-甲氧基吡啶-2-基)苯基)-4-甲基-7,8-二氢吡啶并[4,3-d]嘧啶-5(6H)-酮

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

934526-89-3 / MFCD034526893
Pilaralisib
2-氨基-N-(3-(N-(3-((2-氯-5-甲氧基苯基)氨基)喹喔啉-2-基)磺胺基)苯基)-2-甲基丙酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

937263-43-9 / MFCD037263439
4,6-Quinazolinediamine, N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-
N6-(4,5-二氢-4,4-二甲基-2-恶唑基)-N4-[3-甲基-4-([1,2,4]三唑[1,5-a]吡啶-7-基氧基)苯基]-4,6-喹唑啉二胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国

500-38-9 / MFCD00002206
4,4’-(2,3-Dimethylbutane-1,4-Diyl)Bis(Benzene-1,2-Diol)
4,4’-(2,3-二甲基丁-1,4-二基)双(苯-1,2-二醇)

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国
北京市
√

366017-09-6 / MFCD09954135
Mubritinib
木利替尼

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

HER2

下级目录

目录项下的产品

Products Indices

Mailings

Contact

链接

搜索结果

HER2

下级目录

目录项下的产品

Products Indices

Mailings

Contact

链接